Max Boost Test Support
Max Boost Test Support, licence 80076227: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Atma Nutrition Max Boost Test Support
- Licence holder
- Atma Nutrition
- NPN or DIN-HM
- 80076227
- Status
- Active licence
- Licence date
- 20 March 2017
- Revision date
- 24 August 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Niacine Source : Niacine | 10.0 mg | Not calculated |
| Panax ginseng Source : Racine | 25.0 mg | Not calculated |
| Zinc Source : Oxyde de zinc | 7.5 mg | 7,500 µg |
| Cuivre Source : Cuivre | 1.0 mg | 1,000 µg |
| Trigonella foenum-graecum Source : Plante entière | 300.0 mg | Not calculated |
| Tribulus terrestris Source : Sommité | 50.0 mg | Not calculated |
| Lepidium meyenii Source : Tubercule Extract : Matériel brut sec Extraction ratio : 60:1 Dry plant equivalent : 3000 mg | 50.0 mg | Not calculated |
Non-medicinal ingredients
farine de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Helps to support emotional aspects of sexual health. Helps to support healthy mood balance during menopause.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient. Zinc supplementation can cause a copper deficiency. If you are unsure whether you are taking enough copper, consult a health care practitioner prior to use.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persists or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a healthcare practitioner prior to use if you are taking antidepressants, blood thinners, digoxin, have high blood pressure or diabetes, or suffer from any psychological disorder and/or condition such as frequent anxiety or depression.
Source
Official Health Canada record, licence 80076227
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.